drugset

drugset / Trial / NCT00443625

Phase 1 Study of SK3530 to Investigate of the Effect of Food

NCT00443625 ↗

Phase 1 Completed 15 enrolled SK Chemicals Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed to investigate the food effect of SK3530 on the pharmacokinetics (PKs).

Timeline

Start: 2006-12
Primary completion: 2007-02
Completion: 2007-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mirodenafil	Small molecule	—	—

Indications